Noble Laureate in Medicine (1998) Prof. Dr Ferid (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.
In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor TPM1 via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor TPM1 via up regulation of its target gene, 15/February/2014, 14.35, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
